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Clinical Medicine and Surgery, Federico II UnivAbstract Background: We aimed to examine the association between chocolate intake and the
risk of incident heart failure in a UK general population. We conducted a systematic review and
meta-analysis to quantify this association.
Methods and results: We used data from a prospective population-based study, the European Pro-
spective Investigation into Cancer (EPIC)-Norfolk cohort. Chocolate intake was quantiﬁed based
on a food frequency questionnaire obtained at baseline (1993e1997) and incident heart failure
was ascertained up to March 2009. We supplemented the primary data with a systematic review
and meta-analysis of studies which evaluated risk of incident heart failure with chocolate con-
sumption. A total of 20,922 participants (53% women; mean age 58  9 years) were included
of whom 1101 developed heart failure during the follow up (mean 12.5  2.7 years, total person
years 262,291 years). After adjusting for lifestyle and dietary factors, we found 19% relative
reduction in heart failure incidence in the top (up to 100 g/d) compared to the bottom quintile
of chocolate consumption (HR 0.81 95%CI 0.66e0.98) but the results were no longer signiﬁcant
after controlling for comorbidities (HR 0.87 95%CI 0.71e1.06). Additional adjustment for poten-
tial mediators did not attenuate the results further. We identiﬁed ﬁve relevant studies including
the current study (N Z 75,408). The pooled results showed non-signiﬁcant 19% relative risk
reduction of heart failure incidence with higher chocolate consumption (HR 0.81 95%CI 0.66
e1.01).
Conclusions: Our results suggest that higher chocolate intake is not associated with subsequent
incident heart failure.
ª 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the
Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Feder-
ico II University. Published by Elsevier B.V. All rights reserved.olwarth Building, School of Medicine & Dentistry, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD,
957; fax: þ44 (0) 1603 286428.
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Chocolate consumption and incident heart failure 723Introduction
Cocoa, one of the main ingredients in plain chocolate, is an
important dietary source of ﬂavonoids which are believed
to have cardiovascular beneﬁts. Both observational and
trial evidence have shown that chocolate consumption is
associated with a reduction in blood pressure [1e4]. This
reduction in blood pressure is thought to be due to
enhancement of endothelial nitric oxide production [5,13]
and inhibition of angiotensin converting enzyme [6,7].
Flavonoids also increase antioxidant capacity and diminish
the production of oxidative products in the plasma [8] and
cocoa (one of the ingredients) has been shown to inhibit
oxidation of low density lipoprotein (LDL) [9]. Moreover,
the intake of chocolate and cocoa-based products in-
creases high density lipoprotein (HDL) cholesterol [10],
reduces inﬂammation [11,12] and inhibits platelet aggre-
gation [13]. Indeed, we have recently reported that
habitual chocolate consumption is associated with lower
cardiovascular risk [14]. These factors in combination may
reduce the incidence of heart failure with higher chocolate
consumption.
Existing observational studies evaluating the risk of
heart failure with chocolate consumption show conﬂicting
results and are not directly applicable to the general
population. They were conducted in highly selective pop-
ulations such as women who underwent mammography
[15], older women who received calcium therapy [16], in
those after myocardial infarction [17], and among male
physicians [18]. To date, there has not been a study on the
general population which evaluates the relationship be-
tween habitual chocolate intake and subsequent risk of
heart failure.
In this paper, we report results from a large prospective
UK population study, the European Prospective Investiga-
tion into Cancer-Norfolk (EPIC-Norfolk), and quantify the
effect of chocolate consumption on heart failure incidence
by conducting a systematic review and meta-analysis,
including the current study.
Methods
EPIC-Norfolk cohort study
The study methods of the European Prospective Investi-
gation into Cancer (EPIC)-Norfolk have been previously
described in detail [19]. In brief, this is a prospective
population study of 25,639 men and women, resident in
Norfolk, United Kingdom (99.6% white Caucasian). A
baseline survey was conducted between 1993 and 1997.
Participants completed a health and lifestyle questionnaire
and attended a health examination at their general prac-
titioner’s clinic where a non-fasting venous blood sample
was taken and stored.
The data collection methods are described in Appendix
1. Measurements of height, weight, body mass index;
laboratory methods; ascertainment of education status,
social class, self-reported physical activity, smoking status,
alcohol consumption, and identiﬁcation of participants’co-morbid conditions using questionnaires have been
described in previous studies [19e22]. A food frequency
questionnaire (FFQ) was used to assess overall diet in the
past year [23,24].
A one year recall of chocolate consumption was esti-
mated using three questions from the FFQ and these
questions were consumption of: “Chocolates singles or
squares” (average portion size of 8 g), “Chocolate snack
bars, e.g. Mars, Crunchie” (average portion size of 50 g) and
“Cocoa, hot chocolate (cup)” (average portion size of 12 g
powder weight). The amount of chocolate product eaten
(grams/day) was derived from multiplying the frequency
categories by the portion size. The sum of the weights of
these food items consumed, rather than their ﬂavonoid or
cocoa content, formed the measure of exposure. Chocolate
intake ranged from 0 to 348 g/d. We excluded participants
with chocolate intake greater than 100 g/d (nZ 68), since
generalization of the results to such high quantities
seemed unjustiﬁed. Equally, errors (i.e. outliers) relating to
participant’s poor comprehension of FFQs in general, or
speciﬁcally the questions on chocolate products, were
hereby minimized.
Ascertainment of heart failure incidence
Hospital admissions for participants were identiﬁed using
the participant’s unique National Health Service number
and linking this to the ENCORE (East Norfolk COmmission
REcord) database. All participants were ﬂagged for death
certiﬁcation at the UK Ofﬁce of National Statistics, ascer-
taining vital status for the entire cohort. Incident heart
failure cases were ascertained by using death certiﬁcate
data and hospital record linkage using the “International
Classiﬁcation of Disease-10” (ICD10) code I50 with virtu-
ally complete follow up [22]. Heart failure ascertainment
has been previous validated and reported [25]. We re-
ported data with follow-up up to March 2009, an average
of 12.5 years. The study was approved by the Norwich
District Health Authority Ethics Committee. All partici-
pants provided signed informed consent.
Statistical analysis
Statistical analysis was conducted using STATA 14.0 (Stat-
Corp, College Station, USA). We categorized chocolate
consumption into quintiles. The participants in the ﬁrst
quintile consumed no chocolate. Baseline characteristics
were compared between the quintile groups of chocolate
consumption using one-way analysis of variance (ANOVA)
for continuous variables and chi-squared test for categor-
ical variables. We excluded participants with prevalent
baseline heart failure (where prevalent heart failure was
deﬁned using self-reported intake of drugs recommended
for heart failure at the time of the survey, essentially loop
diuretics in combination with digitalis or angiotensin
converting enzyme inhibitors [22,26]), cancer as well as
participants with missing data on any of the variables
included in the models. The bottom quintile (i.e. non-
consumers) was used as the reference category for all
724 C.S. Kwok et al.risk estimates. Hazard ratios and corresponding 95% con-
ﬁdence intervals (95%CI) for the risk of incident heart
failure were calculated using a Cox proportional hazards
model.
The ﬁve different levels of adjustment for confounders
are described in Appendix 2. In brief, cumulative models
were constructed to control for potential lifestyle factors
and co-morbid conditions (age, sex (model 1), lifestyle
including dietary data: education, body mass index, social
class, physical activity, smoking, dietary energy and
alcohol consumption (model 2) and medical conditions
that may contribute to the pathogenesis of heart failure:
diabetes, myocardial infarction and arrhythmias (model
3)). We included other potential mediators (systolic blood
pressure, cholesterol levels and heart rate [22]) in models
4a, b, and c, respectively. We then performed stratiﬁed
analysis using model 3 for subgroups of participants based
on: sex, age (<65 vs 65 years), body mass index (<25
vs 25 kg/m2), physical activity (active vs non-active),
energy intake (<median energy vs median energy),
prior myocardial infarction, prior diabetes and prior
arrhythmia. We formally tested for interaction by
comparing the model with and without interaction term
using the P-value of the likelihood ratio test (LRT). The
interaction terms were presented graphically.
We also conducted a sensitivity analysis excluding
participants who had incident heart failure within the ﬁrst
3 years of the follow-up.
Systematic review and meta-analysis
We aimed to identify studies that reported on the associ-
ation between chocolate consumption and incident heart
failure. We searched PubMed and EMBASE from inception
until December 2013 using the terms (cocoa OR chocolate)
AND (heart failure OR cardiac failure OR congestive cardiac
failure OR left ventricular dysfunction), with no language
restrictions and we checked bibliographies of included
articles. We set up an automated search on PubMed for
updates (most recent April 2015) on newly published
studies with terms such as ‘chocolate’ and ‘heart or cardiac
or cardiovascular’. We also performed a search of ESC 365
for unpublished studies. Two reviewers independently
screened abstracts and titles, and then obtained full-text
versions of potentially relevant studies to conﬁrm eligi-
bility. Studies were included if they evaluated chocolate
intake and incident heart failure. Data extraction of
included studies was performed by CSK and this was
checked by YKL. We pooled data using the inverse variance
method and random effects model in RevMan 5.2 software
(Nordic Cochrane Center, Copenhagen, Denmark). For
these comparisons, we considered subgroups of women,
men, both genders combined and all studies irrespective of
gender. We used the multivariable adjusted measures of
association (hazard ratios, relative risks or odds ratios) for
the highest category of chocolate consumption versus the
lowest category of consumption. Heterogeneity was esti-
mated using I2 where values greater than 50% were
considered to have substantial heterogeneity [27]. In thecase where a pooled estimate from meta-analysis con-
tained more than 10 studies and there was no evidence of
signiﬁcant heterogeneity, we intended to evaluate publi-
cation bias using asymmetry testing in accordance to the
recommendations by Ioannidis et al. [28].
Results
EPIC-Norfolk study
After excluding participants with prevalent cancer and
heart failure at the baseline, a total of 20,922 participants,
9738 men and 11,184 women were included in the study
(Appendix 3). The cohort’s mean age at baseline was
58.0  9.0 years and 53% were women. The mean follow
up was 12.5  2.7 years (total person years 262,291 years)
during which 1101 individuals developed incident heart
failure. A total of 4236 (20.3%) participants consumed no
chocolate (less than once per month) in the past year.
The characteristics of participants according to quin-
tiles of daily chocolate consumption are shown in Table 1.
The highest consumers of chocolate consumed more than
15.5 g/d of chocolate while the participants in the bottom
group consumed no chocolate. Higher chocolate con-
sumption was signiﬁcantly associated with a younger age
and a lower systolic blood pressure, as well as a lower
proportion of people with hypertension, myocardial
infarction and diabetes, but associated with higher en-
ergy intake. The overall rates of incident heart failure
were lower with higher chocolate consumption; crude
rates were 3.3 events/1000 years and 5.7 events/1000
years in the highest and the lowest categories,
respectively.
Association between chocolate consumption and incident
heart failure in the EPIC-Norfolk cohort
Table 2 shows that the highest chocolate consumption
category was associated with lower risk estimates of
incident heart failure in the age and sex adjusted model
(HR 0.75 95%CI 0.62e0.91). However after adjustment for
lifestyle factors and potential causal chronic co-
morbidities, there was no signiﬁcant difference between
the highest consumers and no consumption of chocolate
(HR 0.87 95%CI 0.71e1.06, Model 2). Further adjustments
for all factors in a single model (Model 3), did not atten-
uate the results further and showed similar non-signiﬁcant
results (HR 0.87 95%CI 0.71e1.06).
Secondary analyses were conducted considering sub-
groups of participants (Table 3). The highest consumers of
chocolate were associated with a lower risk of heart failure
in the subgroup of participants with energy intake below
the median (HR 0.68 95%CI 0.47e0.97). Models including
an interaction term did not show signiﬁcant improvement
compared to model 3 in the prediction of incident heart
failure (Appendix 4). In sensitivity analysis, we excluded
participants with incident heart failure during the ﬁrst 3
years (n Z 88) and observed similar results (data not
shown).
Table 1 Sample characteristics by chocolate intake of 20,922 men and women of the EPIC-Norfolk cohort at the study baseline (1993e1997) and
incident heart failure at respective follow up March 2009.
Quintiles of daily chocolate intake Quintile 1
(n Z 4236)
Quintile 2
(nZ 3521)
Quintile 3
(n Z 4386)
Quintile 4
(nZ 4582)
Quintile 5
(n Z 4198)
p-value*
Range (g/day) 0 0.6e3.4 3.5e6.9 7.0e15.5 15.6e98.8
Median (IQR) (g/day)
Chocolate intake 0 0.8 (0.6, 1.4) 4.1 (4.1, 4.9) 8.7 (8.0, 12.0) 24.9 (22.1, 39.5)
Chocolate singles 0 0.6 (0.6,1.1) 0.6 (0, 1.1) 1.1 (0, 3.4) 1.1 (0.6, 3.4)
Chocolate bars 0 0 3.5 (3.5, 3.5) 7.0 (3.5, 7.0) 21.5 (21.5, 21.5)
Chocolate beverages 0 0 (0, 0.8) 0 (0, 0.8) 0 (0, 5.2) 0 (0, 5.2)
Sex, women 53 (2236) 56 (1962) 56 (2441) 54 (2455) 50 (2090) <0.001
Age, years 60  9 60  9 57  9 58  9 57  9 <0.001
Body mass index, kg/m2 26.4  4.0 26.2  3.8 26.3  3.6 26.2  3.8 26.1  3.7 <0.001
Current smoker 10 (428) 10 (369) 11 (486) 12 (547) 13 (564) <0.001
Self-reported diabetes 6 (235) 2 (60) 1 (60) 1 (47) 1 (31) <0.001
Self-reported hypertension 16 (691) 14 (494) 13 (590) 13 (587) 12 (495) <0.001
Self-reported myocardial infarction 4 (168) 3 (108) 2 (108) 2 (114) 2 (92) <0.001
Self-reported arrhythmia 6 (239) 6 (194) 4 (190) 5 (225) 5 (213) 0.050
Total cholesterol, mmol/L 6.2  1.2 6.2  1.1 6.1  1.1 6.2  1.2 6.1  1.2 <0.001
Systolic blood pressure, mmHg 137  18 136  18 135  18 135  18 134  17 <0.001
Heart rate, beats/minute 71  12 71  12 70  12 71  12 71  11 0.79
Social class <0.001
I 6 (268) 8 (285) 7 (318) 7 (333) 6 (271)
II 34 (1429) 41 (1433) 39 (1698) 35 (1630) 36 (1496)
III non-manual 16 (685) 17 (590) 16 (692) 16 (754) 17 (739)
III manual 25 (1041) 20 (712) 23 (1008) 23 (1078) 24 (996)
IV 15 (630) 11 (398) 13 (562) 13 (618) 13 (556)
V 4 (183) 3 (103) 2 (108) 4 (168) 3 (140)
Education <0.001
No qualiﬁcation 40 (1702) 34 (1181) 34 (1499) 35 (1616) 34 (1445)
O-level 10 (420) 10 (365) 11 (464) 11 (514) 11 (448)
A-level 40 (1682) 41 (1440) 41 (1799) 41 (1867) 43 (1784)
Degree or higher 10 (432) 15 (535) 14 (624) 13 (584) 12 (521)
Physical activity <0.001
Inactive 34 (1420) 29 (1037) 27 (1196) 27 (1256) 28 (1158)
Moderately inactive 27 (1153) 30 (1070) 29 (1283) 30 (1375) 28 (1167)
Moderately active 21 (907) 23 (818) 24 (1057) 23 (1048) 24 (1023)
Active 18 (756) 17 (596) 19 (850) 20 (902) 20 (850)
Energy intake by FFQ, kJ/day 7812  2291 8104  2265 8339  2309 8928  2411 9926  2666 <0.001
Alcohol by FFQ, g/day 8.8  14.4 9.3  13.0 9.2  13.1 8.3  12.0 8.4  12.2 <0.001
Incident heart failure 7 (302) 6 (201) 5 (206) 5 (221) 4 (171) <0.001
Data are presented as mean  SD, percentage (number) or median (IQR).
*P-value determined by analysis of variance (ANOVA) for continuous variables and c2 test for categorical variables for differences among groups.
Table 2 Hazard Ratios for incident heart failure outcome in 20,922 men and women of the EPIC-Norfolk cohort by chocolate consumption.
Quintiles of daily
chocolate intake
Quintile 1
0 g/day
(nZ 4236)
Quintile 2
0.6e3.4 g/day
(nZ 3521)
Quintile 3
3.5e6.9 g/day
(n Z 4386)
Quintile 4
7.0e15.5 g/day
(n Z 4582)
Quintile 5
15.6e98.8 g/day
(nZ 4198)
p-value for trend across
median chocolate intake
in each group
Model 1 1.00 (ref) 0.83 (0.69e0.99) 0.87 (0.73e1.03) 0.78 (0.66e0.93) 0.75 (0.62e0.91) 0.013
Model 2 1.00 (ref) 0.93 (0.78e1.11) 0.97 (0.81e1.16) 0.89 (0.74e1.06) 0.87 (0.71e1.06) 0.193
Model 3 1.00 (ref) 0.92 (0.77e1.11) 0.96 (0.80e1.15) 0.89 (0.74e1.06) 0.87 (0.71e1.06) 0.194
Model 1: Age, sex adjusted.
Model 2: Age, sex, education, body mass index (per unit), social class, physical activity, smoking status, dietary energy (per kJ/day), alcohol
consumption (per g/day), myocardial infarction, diabetes, arrhythmia adjusted.
Model 3: Age, sex, education, body mass index (per unit), social class, physical activity, smoking status, dietary energy (per kJ/day), alcohol
consumption (per g/day), myocardial infarction, diabetes, arrhythmia, systolic blood pressure (per mmHg), cholesterol level (per mmol/L), heart
rate (per beat) adjusted.
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Our search yielded 50 potentially relevant articles and 10
conference presentations. From these results, 4 studiesmet the inclusion criteria (Fig. 1). Details of the included
studies are shown in Table 4. Two of the four studies were
observational [15,17] and two were post-hoc analysis of
randomized trials [16,18]. Two studies only included
Table 3 Subgroup analysis with hazard ratios for incident heart failure outcome in 20,922 men and women of the EPIC-Norfolk cohort by
chocolate consumption.
Quintiles of daily chocolate
intake
Quintile 1
0 g/day
Quintile 2
0.6e3.4 g/day
Quintile 3
3.5e6.9 g/day
Quintile 4
7.0e15.5 g/day
Quintile 5
15.6e98.8 g/day
Likelihood -ratio
test p-value*
Female (nZ 11,184) 1.00 (ref) 0.97 (0.72e1.31) 0.96 (0.72e1.30) 0.89 (0.66e1.21) 0.83 (0.59e1.16) 0.97
Male (n Z 9738) 1.00 (ref) 0.92 (0.73e1.16) 0.97 (0.78e1.22) 0.90 (0.72e1.13) 0.89 (0.69e1.14)
Age <65 years (nZ 14,696) 1.00 (ref) 0.90 (0.63e1.29) 0.85 (0.62e1.18) 0.83 (0.59e1.16) 0.74 (0.52e1.05) 0.56
Age 65 years (nZ 6226) 1.00 (ref) 0.96 (0.78e1.18) 0.93 (0.75e1.15) 0.89 (0.72e1.09) 0.82 (0.66e1.06)
BMI <25 km/m2 (n Z 8379) 1.00 (ref) 1.26 (0.91e1.75) 1.14 (0.81e1.63) 0.95 (0.66e1.35) 1.09 (0.76e1.56) 0.38
BMI 25 km/m2 (n Z 12,543) 1.00 (ref) 0.83 (0.67e1.03) 0.91 (0.74e1.13) 0.87 (0.71e1.07) 0.79 (0.62e1.00)
Inactive (n Z 12,115) 1.00 (ref) 0.87 (0.70e1.08) 0.91 (0.74e1.13) 0.87 (0.70e1.07) 0.86 (0.68e1.09) 0.99
Active (n Z 8807) 1.00 (ref) 1.12 (0.79e1.58) 1.12 (0.79e1.57) 0.95 (0.67e1.34) 0.91 (0.62e1.33)
Low energy intake (nZ 10,457) 1.00 (ref) 0.89 (0.70e1.13) 0.90 (0.71e1.15) 0.76 (0.59e0.99) 0.68 (0.47e0.97) 0.58
High energy intake (n Z 10,465) 1.00 (ref) 0.97 (0.74e1.29) 1.04 (0.79e1.35) 0.95 (0.74e1.22) 0.93 (0.72e1.20)
No prior MI (nZ 20,332) 1.00 (ref) 0.96 (0.79e1.16) 0.98 (0.81e1.19) 0.91 (0.75e1.10) 0.88 (0.71e1.09) 0.98
Prior MI (n Z 590) 1.00 (ref) 0.80 (0.47e1.34) 0.93 (0.58e1.49) 0.76 (0.46e1.28) 0.78 (0.43e1.42)
No prior diabetes (n Z 20,489) 1.00 (ref) 0.95 (0.79e1.15) 1.01 (0.84e1.22) 0.91 (0.75e1.09) 0.90 (0.73e1.10) 0.55
Prior diabetes (nZ 433) 1.00 (ref) 0.93 (0.49e1.77) 0.54 (0.25e1.20) 0.74 (0.34e1.61) 0.50 (0.15e1.65)
No prior arrhythmia
(nZ 19,861)
1.00 (ref) 0.96 (0.79e1.17) 1.03 (0.85e1.24) 0.92 (0.76e1.11) 0.89 (0.72e1.10) 0.45
Prior arrhythmia (nZ 1061) 1.00 (ref) 0.69 (0.40e1.17) 0.55 (0.30e1.01) 0.81 (0.47e1.38) 0.76 (0.44e1.32)
Adjusted for age, sex, education, body mass index (per unit), social class, physical activity, smoking status, dietary energy (per kJ/day), alcohol
consumption (per g/day), myocardial infarction, diabetes, and arrhythmia.
* P-value reﬂects the comparison of the models without and with the interaction term (Please note, the HR presented in the table are from the
stratiﬁed analysis).
726 C.S. Kwok et al.women [15,16] one of which was conducted in women
who underwent mammography [15], and the other one
was conducted in women who were randomized to cal-
cium therapy [16], one included only male physicians [18].
The remaining study included participants after myocar-
dial infarction [17]. One study excluded participants with
previous myocardial infarction [15]. Incident heart failure
outcomes were standardized using International Classiﬁ-
cation of Disease codes in three studies.
All four studies used questionnaires to ascertain choc-
olate consumption, but there was heterogeneity in the way
chocolate consumption was analyzed as one study
considered frequency of chocolate consumption (monthly,
weekly, two or more times weekly) [17], another
compared one or more servings a week [16] and the others
compared different number of servings (1e3 servings/
month, 1e2 servings/week, 3e6 servings/week, 1
serving/day) [15,18]. While all studies made some adjust-
ments for confounders, age was adjusted for in all studies
but smoking, exercise/physical activity and alcohol con-
sumption were adjusted in three studies only [15,17,18].
The pooled results of all the studies suggest that overall
chocolate consumption was associated with a 19% relative
risk reduction in incident heart failure but did not reach
statistical signiﬁcance (RR 0.81 95%CI 0.66e1.01, I2Z 46%)
(Fig. 2). Considering the subgroups in Fig. 1 there were
similar non-signiﬁcant reductions in incident heart failure.
Discussion
In this large prospective population based cohort study,
systematic review and meta-analysis, we found the asso-
ciation between chocolate consumption and reduced
subsequent risk of heart failure but this was notsufﬁciently robust after adjusting for potential con-
founders. This applied to men and women as well as those
with or without baseline heart failure risk factors such as
myocardial infarction, diabetes and arrhythmias. Consid-
ering these results in the context of existing studies, there
appears to be consistent ﬁndings across all studies that
chocolate consumption does not increase the risk of inci-
dent heart failure. We observed modest heterogeneity
across studies and no signiﬁcant association.
The EPIC-Norfolk cohort represents an apparently
healthy middle and older age community dwelling popu-
lation and thus the current study addresses previous lim-
itations such as data from speciﬁc patient populations, or
focused on a particular sex with certain characteristics and
risk proﬁle [15e18].
Previous mechanistic studies have suggested that
chocolate consumption could lower the risk of incident
heart failure through several pathways. Cocoa is rich in
ﬂavonoids which are believed to be responsible for the
cardioprotective properties of chocolate. Flammer et al.
randomized participants with heart failure to ﬂavanol-rich
chocolate or placebo and found that chocolate led to pe-
ripheral vasodilatation, improvement in endothelial func-
tion and inhibition of platelet function [29]. However, their
study was limited due to small sample size and thus no
conclusive evidence was drawn for other outcomes such as
blood pressure and measures of oxidative stress. A meta-
analysis of ten randomized controlled trials has found
that ﬂavanol-rich cocoa products have the capacity to
lower blood pressure [1]. This blood pressure reduction
was thought to be due to ﬂavanol inhibition of angiotensin
converting enzyme [5]. Given the fact that ACE inhibitors
are the cornerstone medical therapy for heart failure, this
effect may be relevant in the observed association with
Figure 1 Search strategy and study selection.
Chocolate consumption and incident heart failure 727heart failure incidence. In addition, a small randomized
study has suggested that cocoa powder and dark chocolate
consumption may modestly reduce LDL oxidation sus-
ceptibility, increase serum total antioxidant capacity and
HDL cholesterol concentrations [30].
There is also evidence to suggest that chocolate has
anti-inﬂammatory [13] and antiplatelet properties
[31,32]. Studies of dark chocolate have further provided
evidence that consumption of chocolate improves endo-
thelial function [33], increases levels of HDL cholesterol
concentration [11] and lower levels of inﬂammation in
the serum [12]. However, a recent study investigating the
impact of dietary ﬂavan-3-ol intake in the EPIC-Norfolk
cohort suggests that the dose is insufﬁcient to confer
cardiovascular beneﬁt so other mechanisms must ac-
count for the current ﬁndings [34]. Although we found
trends towards non-signiﬁcant relative risk reduction,
reverse causality remains the main possible explanation.
We observed that among lower categories of chocolate
consumption there were more people with hypertension,
previous myocardial infarction and diabetes. It may be
that these participants with cardiovascular risk factors
consumed less chocolate.
It should be noted that the chocolate consumption in
the EPIC-Norfolk was skewed (the median consumption
(IQR) was 4.6 (0.56e12)) and we also truncated chocolateconsumption at max of 100 g/d to exclude outliers.
We thus further examined the effect of incremental in-
crease in chocolate consumption and incident heart
failure and there was no evidence for harm (data not
shown). We have recently reported that chocolate con-
sumption was associated with favorable cardiovascular
outcomes [14]. What remains controversial is that while
the beneﬁts of chocolate appear to be in those in the top
quintiles of chocolate consumption, commercially avail-
able chocolate has high calorie content thus when
consumed in high quantity may have adverse conse-
quences because of increased weight gain [35,36] and
diabetes [37]. Therefore, it is possible that in some people
the potential beneﬁts of chocolate outweigh the conse-
quences of increased caloric intake with resultant
adverse effects such as poor diabetes control leading to
complications.
While all studies used food frequency questionnaires to
estimate chocolate consumption, we note that chocolate
intake had no consistent deﬁnition across the studies.
Most of the studies considered chocolate from chocolate
bars while the study by Lewis et al. considered only solid
chocolate and chocolate containing beverages [16]. In the
current study, chocolate intake was derived from chocolate
singles, chocolate bars and chocolate beverages. There was
additional heterogeneity in the way the chocolate intake
Table 4 Studies of chocolate and heart failure.
Study Design, Country Types of
participants
Number of
participants
Exposure
ascertainment
Outcome ascertainment Use of adjustments Results
Janszky 2009
[17]
Cohort study,
Sweden
Non-diabetic
participants post
acute myocardial
infarction in
Stockholm Heart
Epidemiology
Program.
1169 Self-reported usual
chocolate consumption.
Congestive heart failure
events based on ICD-9
and 10 codes.
Adjusted for age, sex,
smoking, obesity,
physical inactivity,
alcohol use, coffee
intake, education and
sweet score.
Congestive heart failure with less
than once per month chocolate
adjusted HR 0.82 (0.56e1.19), up
to once per week chocolate
adjusted HR 0.68 (0.47e0.97),
twice or more a week chocolate
adjusted HR 0.78 (0.52e1.16)
compared to never consumption
of chocolate.
Lewis 2010 [16] Post-hoc
analysis of
RCT, Australia
Older women
randomized to
calcium
supplementation.
1216 Chocolate consumption
using validated
questionnaire.
Heart failure events
based on ICD-10-AM
codes.
Adjusted for age, body
mass index,
socioeconomic status
and energy intake.
Chocolate serving/week 1 vs <1:
event rate 18/637 (2.8%) vs 35/579
(6%); adjusted OR 0.41 0.22e0.76,
p Z 0.01.
Mostofsky 2010
[15]
Cohort study,
Sweden
Middle-aged and
elderly women in
Swedish
Mammography
Cohort.
31,823 Chocolate consumption
using food frequency
questionnaire.
Heart failure events
based on ICD-9 and 10
codes.
Adjusted for total
energy, age, education,
body mass index,
physical activity,
smoking, living alone,
postmenopausal
hormone use, alcohol
consumption, family
history, hypertension
and high cholesterol.
Chocolate vs no chocolate: 1e3
serving/month HR 0.74 (0.58
e0.95), 1e2 serving/week HR 0.68
(0.50e0.93), 3e6 servings/week
HR 1.09 (0.74e1.62), 1 serving/
day HR 1.23 (0.73e2.08).
Petrone 2014
[18]
Post-hoc
analysis of
RCT, USA.
US male physicians
who were
randomized to low-
dose aspirin. b-
carotene, vitamin C,
E and multivitamin
in the Physicians’
Health Study.
20,278 Chocolate consumption
using food frequency
questionnaire.
Heart failure based on
annual follow-up
questionnaires mailed
to each participant and
diagnoses were
previously validated by
reviewing medical
records in a subsample.
Adjusted for age, BMI,
alcohol consumption,
smoking, exercise,
caloric intake and
prevalent atrial
ﬁbrillation.
Chocolate intake frequency and
heart failure (Model 1):
Never or <1/month: HR 1.00
1e3/month: HR 0.86 (0.72e1.03)
1/week: HR 0.80 (0.66e0.98)
2e4/week: HR 0.92 (0.74e1.13)
5þ/week: HR 0.82 (0.63e1.07)
Current study Cohort study,
United
Kingdom
General population. 20,987 Chocolate consumption
based on food
frequency
questionnaire.
Incident heart failure
events based on linkage
to admissions database.
Adjusted for age,
education level, social
class, physical activity,
smoking status, body
mass index, myocardial
infarction, diabetes,
arrhythmia, dietary
energy and alcohol
consumption.
Chocolate consumption in highest
vs lowest quintile: entire cohort
adjusted HR 0.85 95%CI 0.71e1.05.
Subgroup of women adjusted HR
0.81 (0.58e1.13) and subgroup of
men adjusted HR 0.89 (0.69
e1.14).
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Figure 2 Meta-analysis of chocolate consumption and incident heart failure.
Chocolate consumption and incident heart failure 729was categorized. Lewis et al. categorized chocolate intake
from <1 serving/week to 7 servings/week [16]. In the
study by Mostofsky et al. [15], there were 8 predeﬁned
responses ranging from never to 3 times per day for
chocolate intake and Janszky used similar deﬁnitions [17].
Petrone et al. used frequency across the year from never or
less than once per month to up to 5 times weekly [18]. In
the current study, we analyzed the data according to
quintiles of chocolate intake.
We observed that among the highest consumers of
chocolate who had energy intake below the median had a
lower risk of heart failure. It is unclear why this is. One
possible reason for this observation may be that low en-
ergy intake may reﬂect individuals who are of younger
age and younger age is associated with lower heart failure
risk.
While we found that chocolate intake may possibly be
associated with lower likelihood of heart failure, the as-
sociation was not statistically signiﬁcant after adjustments
for potential confounders and mediators. There could still
be a signiﬁcant association but this study may not have
had sufﬁcient sample size and power to detect this. This is
supported by the meta-analysis which pooled existing
studies which all seem to suggest a lower risk in heart
failure with higher chocolate consumption. However, the
positive associations from published literature may also
stem from publication bias whereby studies that show
signiﬁcant associations are more likely to be published
whereas those with null or non-signiﬁcant ﬁndings remain
unpublished. More studies with high quality methods and
adequately powered sample size are needed to determineif there are beneﬁts of chocolate in terms of heart failure
risk.
Our study has several strengths. The current study is
based on a large population-based cohort thus is appli-
cable to the middle and older aged general population. The
characteristics of the EPIC-Norfolk participants were
comparable to other UK representative samples except
with lower prevalence of current smokers [18]. The sample
size was sufﬁciently large to capture a sufﬁcient number of
incident heart failure events. Furthermore, we were able to
account for many potential confounders including, socio-
demographic, lifestyle, physiological, co-morbidity and
dietary factors, which increased the robustness of our
ﬁndings. In addition, clinically signiﬁcant incident heart
failure cases were adequately ascertained from hospital
admissions [38] and death certiﬁcates. Furthermore, we
conducted a systematic review to evaluate how our results
compare with the existing literature and able to quantify
the evidence by conducting a meta-analysis of similar
studies.
Our study has some limitations. The FFQ has limita-
tions associated with it, such as assumptions about
portion size, possible errors in completing the question-
naire due to memory and extended recall time of 1 year.
Some participants may under-report especially with
chocolate consumption. This could mean that the high
chocolate consumers are people with more ‘reliable
chocolate intakes’ and possibly with other positive be-
haviors or characteristics which lower risk of a cardiac
outcome. We were unable to differentiate plain, milk and
dark chocolate in this study and therefore unable to
730 C.S. Kwok et al.determine the effect of the different types of chocolate.
Mild cases of heart failure might have been missed at
baseline. However, sensitivity analysis excluding those
diagnosed with heart failure within the ﬁrst 3 years of
follow up did not alter the results. Studies have shown
that many patients with left ventricular systolic
dysfunction are asymptomatic, undetected and untreated
[39,40]. However, the use of hospital records would
identify the most clinically relevant cases of heart failure.
The evaluation of chocolate across all studies included in
our systematic review lacked consistency deﬁning high
or low intake and also varied in ascertaining chocolate
consumption which introduced modestly high heteroge-
neity in the meta-analysis.
It is worth noting that while chocolate consumption
may be associated with potential cardiovascular beneﬁt
with regard to incidence of stroke and ischemic cardio-
vascular disease; the different pathophysiological process
which underpins the development and progression of
heart failure is very different from ischemic pathology. The
initial inverse association between higher chocolate con-
sumption and incident heart failure was attenuated by
adjustment of confounders and potential mediators.
Nevertheless, we observed an unlikely increased harm
from higher chocolate consumption with regard to the risk
of developing subsequent heart failure in this general
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Appendices
Appendix 1. Description of data collection
Education status was recorded as degree or equivalent, A-
level or equivalent, O-level or equivalent, and less than O-
level or no qualiﬁcations [1]. Social class was classiﬁed
according to the Registrar General’s occupation-based
classiﬁcation scheme where social class I consists of pro-
fessionals (e.g. Doctors and lawyers), class II includes
managerial and technical occupations, class III is sub-
divided into non-manual and manual skilled workers (III
non-manual and III manual), class IV consist of partly
skilled workers, and class V comprises of unskilled manual
workers [1]. Physical activity was assessed with two
questions referring to usual physical activity at work, and
physical activity outside work, during the past year [1].
The responses to these questions were used to allocate
participants as: inactive (sedentary job and no recreational
activity), moderately inactive (sedentary job with <0.5 h
recreational activity per day or standing job with no rec-
reational activity), moderately active (sedentary job with
0.5e1 h recreational activity per day or standing job with
<0.5 h recreational activity per day or physical job with no
recreational activity); and active (sedentary job with >1 h
recreational activity per day or standing job with >1 h
recreational activity per day or physical job with at least
some recreational activity or heavy manual job).
Smoking history was obtained from yeseno responses
to the questions: “Have you ever smoked as much as one
cigarette a day for as long as a year?” and “Do you smoke
cigarettes now?” and the responses were used to catego-
rize participants as never or former smokers and current
smokers [2]. Trained nurses examined each participant at a
clinic visit. Height and weight were measured, and body
mass index (BMI) was estimated as weight (kg) divided by
height squared (m2) [3]. Blood pressure and heart rate
were measured twice with an Accutorr non-invasive blood
pressure monitor (Datascope Medical, Huntington, UK)
after the participant had been seated for 5 min and the
mean of two measurements was used for the analysis [3].
Blood samples were obtained using standard protocols
and plasma was stored at 70 C before total cholesterol
concentrations were measured by colorimetry (RA 1000;
Bayer Diagnostics, Basingstoke, UK) [1]. LDL cholesterol
was calculated by the Friedewald formula. Participants
were asked the question, “Has the doctor ever told you
that you have any of the following?” and this was followed
by a checklist to include myocardial infarction, cancer,
diabetes and arrhythmia in order to identify known co-
morbidities [1].
A food frequency questionnaire (FFQ) was used to
assess overall diet in the past year. Food items in the
questionnaire had nine answer categories: never or less
than once per month, 1e3 per month, once a week, 2e4
per week, 5e6 per week, once a day, 2e3 per day, 4e5 per
Chocolate consumption and incident heart failure 731day, 6þ per day. This instrument and the way it is analyzed
using the Compositional Analyses from Frequency Esti-
mates (CAFÉ) and FFQ EPIC Tool for Analysis (FETA), are
described in detail elsewhere [4,5]. Alcohol consumption
was derived from a questionnaire containing selected
foods collected at the baseline clinic visit and the average
alcohol consumption in grams/day was calculated [1].
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